Onkologia Medikoa

2024

1. A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis

   JNCI Cancer Spectrum, Vol. 8, Núm. 3

2. A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer

   Breast Cancer Research, Vol. 26, Núm. 1

3. A randomized controlled trial of the effectiveness of a one-to-one peer support intervention on resilience, social support, and salivary cortisol in recently diagnosed women with breast cancer

   European Journal of Oncology Nursing, Vol. 71

4. A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies

   Cancer Treatment Reviews, Vol. 128

5. Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant eR+ breast cancer

   Science Translational Medicine, Vol. 16, Núm. 736

6. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

   Lung Cancer, Vol. 194

7. Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective

   Cancers, Vol. 16, Núm. 1

8. Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients

   Clinical and Translational Oncology

9. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

   Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328

10. Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

    Gynecologic Oncology, Vol. 184, pp. 168-177

11. Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

12. Impact of COVID-19 infection on genitourinary cancer management. SOGUG-COVID-19: A spanish, multicenter, observational study

    Clinical and Translational Oncology

13. Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives

    Cancer Treatment Reviews, Vol. 127

14. Leveraging Large Language Models for Precision Monitoring of Chemotherapy-Induced Toxicities: A Pilot Study with Expert Comparisons and Future Directions

    Cancers, Vol. 16, Núm. 16

15. Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study

    ESMO Open, Vol. 9, Núm. 10

16. Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer

    Clinical Therapeutics, Vol. 46, Núm. 8, pp. 612-621

17. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms

    Pathology, Vol. 56, Núm. 4, pp. 493-503

18. Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial

    British Journal of Cancer, Vol. 130, Núm. 3, pp. 417-424

19. Posicionamiento del grupo de supervivientes de la SEEO para la atención a los/as largos supervivientes de cáncer

    Enfermería Oncológica, Vol. 26, Núm. 1, pp. 1-3

20. Power of Light: Raman Spectroscopy and Machine Learning for the Detection of Lung Cancer

    ACS Omega, Vol. 9, Núm. 12, pp. 14084-14091